Amazing!

The "bioprosthetic" artificial heart from Carmat
has been implanted in a human being. The
procedure was performed on December 18th at
France's Georges Pompidou European Hospital,
and the patient is said to be doing well. Carmat
says he is currently awake in the intensive care
unit and is speaking with family members.
According to the company, the operation went
"smoothly" and the heart is providing blood flow
as expected. It marks the first successful human
implant for Carmat, with other trials slated for the
future.
Carmat's innovative artificial heart — which
includes sections of cow tissue — initially won
approval in Saudi Arabia, Slovenia, Poland, and
Belgium earlier this year. The company's home
country of France eventually came on board in
September, and Health Minister Marisol Touraine
is wasting no time in touting Carmat's success.
"This news brings great pride to France," she told
BFM TV. "It shows we are pioneers in healthcare,
that we can invent, that we can carry an
innovation that will also bring great hope to
plenty of people." Carmat's CEO Marcelo Conviti
took a more cautious tone. "We are delighted with
this first implant, although it is premature to draw
conclusions given that a single implant has been
performed and that we are in the early
postoperative phase," he said in a statement.
Carmat's artificial heart, which is three times
heavier than a human's, can beat for up to five
years and is designed for patients suffering from
end-stage heart failure. Carmat has other patients
lined up for early human trials; according to
Reuters, the procedures will be deemed
successful for all patients that survive with the
implant for over a month. The heart could help up
to 100,000 patients across the US and Europe,
Carmat says. Assuming other trials go well, price
will continue to be the main barrier of entry;
Carmat's device is priced at around $195,000.



I have no words left . . . . . . Just wanna say STAY TUNED . . . . . . . . .